Diamond’s world-class macromolecular crystallography facility provides cutting-edge capabilities to determine the 3D structures of biological targets, at atomic level.
It enables pharmaceutical, biotech and agrochemical companies to accelerate the identification & validation of lead compounds, whilst giving a clear picture of the interaction between ligand and its target. This precise information helps to orientate the design of new drug candidates in order to improve their potency and selectivity.
Here at Diamond, our MX beamlines incorporate advanced robotic systems with software for automated sample handling, crystal centring and data collection. In addition, microfocus beamlines are perfectly suited for studying small or challenging samples. Tools for serial crystallography and in situ data collection are in place for users to optimise their research.
We have also developed high performance automated processing pipelines for integration, scaling and phasing data in real time for immediate structure analysis at the beamline.
We can help you to make the most out of your MX experience with the support of our dedicated, highly skilled, team of industrial scientists. And of course, if MX is just part of your research journey, we can also provide a range of complementary techniques all available on the same site. These include cryo electron microscopy (eBIC), protein small angle scattering (SAXS), circular dichroism and a fragment screening platform based on X-ray crystallography (XChem).
Benefits of synchrotron MX:
Benefits of MX at Diamond:
Diamond Light Source is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
Copyright © 2020 Diamond Light Source
Diamond Light Source Ltd
Harwell Science & Innovation Campus